TY  - JOUR
AU  - Domínguez, Fernando
AU  - Lalaguna, Laura
AU  - López-Olañeta, Marina
AU  - Padrón-Barthe, Laura
AU  - Román, Marta
AU  - Bello-Arroyo, Elísabet
AU  - Briceño, Ana
AU  - Gonzalez-Lopez, Esther
AU  - Segovia-Cubero, Javier
AU  - García-Pavía, Pablo
AU  - Lara-Pezzi, Enrique
AU  - Villalba Orero, María
PY  - 2021
DO  - 10.1161/circheartfailure.120.007616
SN  - 1941-3289
SN  - 1941-3297
UR  - https://hdl.handle.net/20.500.14352/97978
T2  - Circulation: Heart Failure
AB  - Background: Arrhythmogenic right ventricular cardiomyopathy type 5 (ARVC5) is an inherited cardiac disease with complete penetrance and an aggressive clinical course caused by mutations in TMEM43 (transmembrane protein 43). There is no cure for ARVC5...
LA  - eng
M2  - E007616
PB  - Lippincott Williams and Wilkins
KW  - arrhythmogenic right ventricular dysplasia
KW  - cardiomyopathies
KW  - fibrosis
KW  - heart failure
KW  - translational medical research
TI  - Early Preventive Treatment With Enalapril Improves Cardiac Function and Delays Mortality in Mice With Arrhythmogenic Right Ventricular Cardiomyopathy Type 5
TY  - journal article
VL  - 14
ER  -